Cytek® Biosciences, Inc. ('Cytek Biosciences” or 'Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025.

The study showcases an innovative and effective approach for large-scale genomic research of individual cells and viral ...

According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...

As time marches on, aging is inevitable. Naturally, a person can accumulate wrinkles, laugh lines, stress, and cellular damage. Of these, damaged cells can take multiple paths: they can undergo ...